Where was chem research conducted? Not here, say two of three listed author affiliations

ChemosphereA researcher has retracted two 2016 papers after discovering problems with the data that negated the findings — and after one of his three listed affiliations denied the research was conducted there.

According to the retraction notices issued by Chemosphere, Hong-Wei Luo incorrectly claimed to be affiliated with the Oak Ridge National Laboratory (ORNL) in Tennessee in one of his three affiliations. His other institutions listed on the papers include universities in Singapore and China.

However, an official from the Nanyang Technological University (NTU) in Singapore, told us the work in the now-retracted papers was not carried out at the NTU either.

Here’s the first of the retraction notices, issued on August 8: Continue reading Where was chem research conducted? Not here, say two of three listed author affiliations

Author loses five papers, most for “compromised” peer review

PLOS OnePLOS ONE has retracted three papers after the first author admitted to submitting the manuscripts without co-authors’ consent, and an investigation suggested that two out of the three papers had received faked reviews.

Last August, the same author — Lishan Wang of the Shanghai Jiao Tong University — lost two more papers (one in Tumor Biology and the other in Gene), also after the peer review process was found to be compromised. All five papers — which share other authors in common — were originally published in 2013, and four list Wang as the first author. The retractions follow an investigation by Shanghai Jiao Tong University.

Here’s the retraction notice for two of the PLOS ONE papers, issued on July 26: Continue reading Author loses five papers, most for “compromised” peer review

Beg pardon? Researchers pull cancer paper because, well, um, you see …

dovepressWe’ve been writing about retractions for six years, and things tend to fall into easily recognizable categories — plagiarism, fabricated data, rigged peer review, etc.

So it’s always interesting to come across a notice sui generis, such as one that appeared in July in OncoTargets and Therapy, a Dove title, about a new way to detect tumor markers.

According to the retraction notice:

Continue reading Beg pardon? Researchers pull cancer paper because, well, um, you see …

A headache: Brain paper retracted over author argument

neurochemical researchResearchers have retracted a paper following an argument over who deserves top billing, according to the last author of the paper.

The last author added the authors plan to republish the paper once they work things out.

The work for the paper — about cell death in the aftermath of a brain hemorrhage — was started in one lab at the Department of Neurology at the Affiliated Hospital of Nantong University, and completed in another.

That led to a dispute, reports the retraction notice, issued by Neurochemical Research:

Continue reading A headache: Brain paper retracted over author argument

Why did a chemistry journal fix fraud with a correction instead of a retraction?

Chemical Communciations

Are some cases of research fraud fixable with a correction notice?

A chemistry journal thought so in 2014, when it issued a correction notice for a 2012 paper after the first author admitted to manipulating an image. After an investigation, the publisher agreed the manipulation was a “clear breach” of its ethical guidelines, but decided not to retract the paper since the overall conclusions remain valid.

The last author told us the first author had to repeat the experiments under supervision, and received a “serious warning.”

It’s an older notice, but one we thought interesting enough to cover now. Once you’ve read through the journal’s reasoning, tell us if you agree with the decision to correct (rather than retract) the paper in a poll at the bottom of this post.

Here’s the correction for “A novel route for preparing highly proton conductive membrane materials with metal-organic frameworks,” issued by Chemical Communications:

Continue reading Why did a chemistry journal fix fraud with a correction instead of a retraction?

PhD student expelled for submitting paper without co-authors’ consent

PLOS OneA PhD student has been expelled from a university in China after publishing a paper in PLOS ONE without the permission of her co-authors, and using an external company to complete some of the work. 

PLOS ONE has now retracted the paper, noting that they were tipped off to the problems by a reader who raised concerns about some of the figures. The notice states that the study’s first author, Zhenni Zhang, takes full responsibility. 

The last author of the paper Zongfang Li from the Xi’an Jiaotong University in China — told us Zhang was his PhD student who was close to completing her PhD, but has now been expelled.

Here’s the retraction notice, issued on July 25: Continue reading PhD student expelled for submitting paper without co-authors’ consent

Journal retracts paper for using figures without permission

A plastic surgery journal has retracted a paper after a researcher claimed it contained three figures without his permission.

According to Aesthetic Surgery Journal’s retraction notice (which is paywalled, tsk tsk), the figures were reproduced from a paper published in a Chinese journal without the original authors’ knowledge or permission: Continue reading Journal retracts paper for using figures without permission

Biochem journal retracts paper for “striking level of similarity” with another

Molecular and Cellular Biochemistry CoverA biochemistry journal has pulled a paper after deciding that its layout and content overlapped significantly with a previously published paper.

The researcher who reported the similarity to Molecular and Cellular Biochemistry has sent us his correspondence with the journal. After a “thorough investigation,” the journal felt the paper was worth retracting.

Here’s the retraction notice for “TNF receptor-associated factor 6 regulates proliferation, apoptosis, and invasion of glioma cells:” Continue reading Biochem journal retracts paper for “striking level of similarity” with another

Researcher faked emails for co-authors, submitted paper without consent

A material science journal has retracted a paper after discovering that the first author faked email addresses for co-authors to submit the paper without their permission.

The journal, Materials, also discovered that the 2016 paper had plagiarized material from a 2013 paper previously published in Metallurgical and Materials Transactions A.

Here’s the retraction notice for the paper: Continue reading Researcher faked emails for co-authors, submitted paper without consent

Is China using organs from executed prisoners? Researchers debate issue in the literature

Journal of Medical EthicsA researcher is calling for the retraction of a paper about a recent ban in the use of organs from executed prisoners in China, accusing the authors of misrepresenting the state of the practice.

In April 2015, a paper in the Journal of Medical Ethics welcomed the ban by the Chinese government as “a step in the right direction,” but noted that China remains plagued by a crucial shortage in available organs.

Some academics disagreed with the authors’ take on the issue, noting that the paper fails to note that many organs may continue to be harvested from Chinese prisoners of conscience; ultimately, the journal received a letter asking to retract the paper. The journal decided not to, and instead asked the authors to issue a lengthy correction, for instance changing the language about the government decision (“law” became“guideline”), and allowed critics to publish a rebuttal to the paper in May 2016.  Continue reading Is China using organs from executed prisoners? Researchers debate issue in the literature